<DOC>
	<DOCNO>NCT00825669</DOCNO>
	<brief_summary>Hepatectomy still treatment choice hepatocellular carcinoma . Part patient may present portal vein tumor thrombus ( PVTT ) resection . PVTT might lead upper gastrointestinal bleeding worsen hypersplenism endanger life patient . PVTT also play centre role recurrence metastasis HCC . There standard treatment PVTT yet . We aim compare effect TACE TACE plus laser ablation treat patient PVTT .</brief_summary>
	<brief_title>Treatment Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection</brief_title>
	<detailed_description>Hepatectomy still treatment choice hepatocellular carcinoma , prognosis agreeable . Part patient may present portal vein tumor thrombus ( PVTT ) resection . PVTT might increase pressure portal vein lead upper gastrointestinal bleeding worsen hypersplenism endanger life patient . PVTT also play centre role recurrence metastasis HCC . There standard treatment available PVTT yet . TACE mostly often use treat PVTT . We aim compare effect TACE TACE plus laser ablation treat patient PVTT .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>1 . PVTT liver resection diagnose least two type image finding , CT , MRI color doplor finding . 2 . The function kidney , heart lung routine test blood good condition . 3 . The liver function grade A B ChildPugh classification . 4 . The patient eligible trial show consent test . 1. parameter . WBC le 2000/ml , Hb le 90g/L PLT less 50000/ml . 2. disfunction heart , lung , kidney , brain . 3. disease might affect trial . 4. patient would sign consent trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>Portal vein tumor thrombus</keyword>
	<keyword>laser ablation</keyword>
</DOC>